Skip to content

FLAMIN-GO

From pathobiology to synovia on chip: driving rheumatoid arthritis to the precision medicine goal

WELCOME

FLAMIN-GO’s Vision

FLAMIN-GO’s VISION is to provide an organ-on-chip solution to open up a new avenue towards personalized care in RA. This solution will be based on the design and fabrication a multi-compartment microfluidic platform, for 3D culturing and perfusion, of all the disease-relevant joint tissues, focusing on synovia and synovial fluid, which are the pathogenetic targeted tissues, but including immune system (vessels and leukocytes) who sustain the disease, as well as cartilage and bone which are the end damaged tissues, leading to permanent disability. The integration with a lab-on-chip and several sensors will allow to monitor continuously culturing conditions and response to drugs.

Rheumatoid Arthritis? Chip it!

News

AI-TWIN at EUROoCS2024 meeting

AI-TWIN members add tag Annalisa, Francesca, Beatrice, and Alessandro attended the EUROoCS2024 meeti…

FLAMIN-GO’s 4th interim meeting in Slovenia: “We identified key adjustments that will enhance our progress”

Ljubljana, Slovenia The Flamin-Go project, a pioneering initiative aimed at revolutionizing rheumato…

multiethnic students and teacher listening report of student
Is precision medicine the answer to disease treatment?

On Thursday, 20. 06. 2024 at 13:00 hrs, you are kindly invited to the semin…

Invitation to SINPAIN/FLAMIN-GO workshop

Together with CIDETEC, the coordinator of the SINPAIN project, we are organizing an o…

FLAMIN-GO attends UnistemDay

On March 22nd, 2024, the scientific outreach event “UnistemDay: The Infinite Journey of Scient…

Personalized

Organ-on-chip, a multi-compartment microfluidic platform offering tailoring and personalized treatment solutions.

Targeted

Focusing on synovia and synovial fluid, which are the pathogenetic targeted tissues, but including immune system who sustain the disease, as well as cartilage and bone

Monitoring

The integration with a lab-on-chip and several sensors will allow to monitor continuously culturing conditions and response to drugs.